Nanox’s Upgraded AI Cardiac Solution Receives FDA Clearance

Nanox’s Upgraded AI Cardiac Solution Receives FDA Clearance

By Karen Roman Medical imaging company Nano-X Imaging Ltd. (Nasdaq: NNOX) said it received clearance from the Food and Drug Administration for HealthCCSng V2.0, an upgraded version of its advanced AI cardiac solution HealthCCSng. HealthCCSng assesses coronary artery calcium levels...

Kohl’s Shares Rally on Bullish Full Year Profit Guidance

Kohl’s Shares Rally on Bullish Full Year Profit Guidance

By Karen Roman Kohl’s Corporation (NYSE: KSS) shares jumped 6% in early trade Wednesday as sales dropped but bullish guidance gave investors cheer. Net sales decreased 4.2% year-over-year to $3.5 billion with comparable sales down 5.1%, while inventory declined 9%,...

MOBILion Appoints Rohit Khanna, Ph.D. to Board of Directors

MOBILion Appoints Rohit Khanna, Ph.D. to Board of Directors

By Karen Roman MOBILion Systems, Inc. said it appointed Rohit Khanna, Ph.D., to serve on its Board of Directors. Dr. Khanna is a life sciences executive with over three decades of experience in the analytical instrumentation industry, the company said in...

Anomali Expands AI Copilot to Boost IT Operations, Risk Management

Anomali Expands AI Copilot to Boost IT Operations, Risk Management

By Karen Roman AI-powered security operations company Anomali announced new capabilities for Anomali Copilot, extending its use to both security and IT departments. Copilot enables analysts to quickly search vast datasets and provides immediate answers in over 80 languages, the...

On Holding Net Sales Jump 28% in Second Quarter

On Holding Net Sales Jump 28% in Second Quarter

  By Daniella Parra On Holding AG (NYSE: ONON) said net sales soared 27.8% to CHF 567.7 million in the second quarter. Adjusted EBITDA margin increased to 16% from 14.1% and basic earnings per share increased to 0.10 from 0.01,...

Crown Laboratories, Revance Enter Merger Agreement

Crown Laboratories, Revance Enter Merger Agreement

By Karen Roman Private skincare company Crown Laboratories, Inc. and biotechnology company Revance Therapeutics, Inc. (NASDAQ: RVNC), made public their merger agreement to become a new combined company. Crown plans to acquire all outstanding shares of Revance’s common stock for...

Input your search keywords and press Enter.